Finn Jonathan 4/A
4/A · ATOSSA THERAPEUTICS, INC. · Filed Nov 15, 2023
Insider Transaction Report
Form 4/AAmended
Finn Jonathan
Director
Transactions
- Award
Stock Option (right to buy)
2023-11-15+62,500→ 62,500 totalExercise: $0.65Exp: 2033-11-15→ Common Stock (62,500 underlying)
Footnotes (1)
- [F1]The options shall vest in four equal quarterly installments following November 15, 2023.